Evaluate Ovulation and PK of Medroxyprogesterone Acetate Following Dose of TV-46046

Study Title
Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle
Teva Identifier
TV46046-WH-10075
ClinicalTrials.gov Identifier
NCT02817464
Study Status
Completed
Trial Condition(s)
Pregnancy | Contraception
Interventions
Drug: TV-46046 - 400 mg/mL | Drug: TV-46046 - 200 mg/mL | Drug: TV-46046 - 300 mg/mL (if warranted)

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female
Age Range
18 Years to 40 Years
Trial Duration
October 7, 2016 - December 3, 2018
Phase
Phase 1

Study Type

Interventional